BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 38012585)

  • 1. Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells.
    Emad B; WalyEldeen AA; Hassan H; Sharaky M; Abdelhamid IA; Ibrahim SA; Mohamed HR
    BMC Cancer; 2023 Nov; 23(1):1151. PubMed ID: 38012585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: A dual-death therapy for triple negative breast cancer.
    Ghadi R; Pandey PK; Gabhale A; Wadikar A; Dharshini M; Kuche K; Date T; Jain S
    Int J Pharm; 2023 Dec; 648():123570. PubMed ID: 37918494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.
    Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L
    Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080
    [No Abstract]   [Full Text] [Related]  

  • 4. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
    Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis.
    Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468.
    Ashourpour M; Mostafavi Hosseini F; Amini M; Saeedian Moghadam E; Kazerouni F; Arman SY; Shahsavari Z
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2079-2087. PubMed ID: 34319030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
    Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
    Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroform Fraction of Methanolic Extract of Seeds of Annona muricata Induce S Phase Arrest and ROS Dependent Caspase Activated Mitochondria-Mediated Apoptosis in Triple-Negative Breast Cancer.
    Kariyil BJ; Ayyappan UPT; Gopalakrishnan A; George AJ
    Anticancer Agents Med Chem; 2021; 21(10):1250-1265. PubMed ID: 32951586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
    Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
    J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfiram/Copper Induce Ferroptosis in Triple-Negative Breast Cancer Cell Line MDA-MB-231.
    Chu M; An X; Fu C; Yu H; Zhang D; Li Q; Man X; Dai X; Li Z
    Front Biosci (Landmark Ed); 2023 Aug; 28(8):186. PubMed ID: 37664913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Proliferative and Pro-Apoptotic Effects of
    Alehaideb Z; AlGhamdi S; Yahya WB; Al-Eidi H; Alharbi M; Alaujan M; Albaz A; Tukruni M; Nehdi A; Abdulla MH; Matou-Nasri S
    J Evid Based Integr Med; 2020; 25():2515690X20978391. PubMed ID: 33302699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer.
    Milane LS; Dolare S; Ren G; Amiji M
    J Control Release; 2023 Nov; 363():435-451. PubMed ID: 37717658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
    Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
    Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced preferential cytotoxicity through surface modification: synthesis, characterization and comparative in vitro evaluation of TritonX-100 modified and unmodified zinc oxide nanoparticles in human breast cancer cell (MDA-MB-231).
    Kc B; Paudel SN; Rayamajhi S; Karna D; Adhikari S; Shrestha BG; Bisht G
    Chem Cent J; 2016; 10():16. PubMed ID: 27042206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Y
    Porosnicu I; Butnaru CM; Tiseanu I; Stancu E; Munteanu CVA; Bita BI; Duliu OG; Sima F
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34199757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of AKT/PI3K Pathway in Sanguinarine's Induced Apoptosis and Cell Cycle Arrest in Triple-negative Breast Cancer Cells.
    Messeha SS; Noel S; Zarmouh NO; Womble T; Latinwo LM; Soliman KFA
    Cancer Genomics Proteomics; 2023; 20(4):323-342. PubMed ID: 37400144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
    Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
    Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzalutamide Overcomes Dihydrotestosterone-Induced Chemoresistance in Triple- Negative Breast Cancer Cells
    Alsawalha L; Ahram M; Abdullah MS; Dalmizrak O
    Anticancer Agents Med Chem; 2022; 22(17):3038-3048. PubMed ID: 35579133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of bio functionalized nanoparticles to attenuate triple negative breast cancer (MDA-MB-231 cells).
    Santhoshkumar M; Perumal D; Narenkumar J; Ramachandran V; Muthusamy K; Alfarhan A; David E
    Bioprocess Biosyst Eng; 2023 Jun; 46(6):803-811. PubMed ID: 36977929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the toxicity effects of copper oxide nanoparticles conjugated with Lapatinib on breast (MDA-MB-231) and lung (A549) cancer cell lines.
    Talarposhti MV; Salehzadeh A; Jalali A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38563880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.